NP Life Sciences Health Industry Group Inc. (ACAT) Net margin 2019–2023
NP Life Sciences Health Industry Group Inc. (ACAT) net profit margin by fiscal year — reported net income divided by reported revenue.
-1.8%FY2023 · since FY2019: -253.1% → -1.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -1.8% | +16.7 pp |
| FY2022 | -18.5% | +169.2 pp |
| FY2021 | -187.7% | +686.1 pp |
| FY2020 | -873.8% | -620.7 pp |
| FY2019 | -253.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ACAT financial trends
ACAT RevenueACAT Net incomeACAT Gross profitACAT Gross marginACAT Operating incomeACAT Operating marginACAT Operating cash flowACAT Free cash flowACAT Capital expendituresACAT Return on equityACAT Stock buybacksACAT Dividends paidACAT Total assetsACAT Total liabilitiesACAT Shareholders’ equityACAT overview →